Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001415889-24-021858

PRESIDENT AND CEO gave up 9,897 shares (to pay taxes)

  • PRESIDENT AND CEO acquired 40,639 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jiang Wenbin PRESIDENT AND CEO 2024-08-19 Option exercise +6,758 5,332,912 D
Jiang Wenbin PRESIDENT AND CEO 2024-08-19 Shares withheld for taxes −1,646 $5.53 $9,102 5,331,266 D
Jiang Wenbin PRESIDENT AND CEO 2024-08-19 Option exercise +11,781 5,343,047 D
Jiang Wenbin PRESIDENT AND CEO 2024-08-19 Shares withheld for taxes −2,869 $5.53 $15,866 5,340,178 D
Jiang Wenbin PRESIDENT AND CEO 2024-08-19 Option exercise +22,100 5,362,278 D
Jiang Wenbin PRESIDENT AND CEO 2024-08-19 Shares withheld for taxes −5,382 $5.53 $29,762 5,356,896 D
Derivatives
Jiang Wenbin PRESIDENT AND CEO 2024-08-19 Option exercise · Restricted Stock Units −6,758 38,304 D
Jiang Wenbin PRESIDENT AND CEO 2024-08-19 Option exercise · Restricted Stock Units −11,781 121,742 D
Jiang Wenbin PRESIDENT AND CEO 2024-08-19 Option exercise · Restricted Stock Units −22,100 316,773 D
Loading xslF345X05/form4-08212024_100843.xml…